Biomea Fusion Inc share price logo

Biomea Fusion Inc

NASDAQ: BMEA

Small Cap

$1.27

-0.10

(-7.30%)

as on

Biomea Fusion Inc Stock Performance

as on June 8, 2026 at 2:16 pm IST

  • Day's High

    $1.27
    $1.37

    7.87%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.87
    $3.08
    downward going graph

    31.35%

    Downside

    142.52%

    Upside

    downward going graph

Biomea Fusion Inc share price movements today

Previous Close
$1.37
Open
$1.37
Volume
1.6M
Day's Low - High
$1.27 - $1.37
52 Week Low - High
$0.87 - $3.08

Biomea Fusion Inc Historical Returns

1 Month Return
-17.53 %
3 Month Return
-8.63 %
1 Year Return
-49 %
3 Year Return
-96.96 %
5 Year Return
-93.8 %

Biomea Fusion Inc Stock Fundamentals & Key Indicators

Check Biomea Fusion Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$91.8M

EPS (TTM)

-1.0082

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-63.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-189.44%

Biomea Fusion Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biomea Fusion Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$91.8M-93.8%NA0.00%NA
BUY$40.5B100.59%76.3312.55%NA
BUY$113.4B111.64%26.5235.51%NA
BUY$66.6B25.48%15.529.65%0.5700000000000001%

Stock Returns calculator for Biomea Fusion Inc Stock including INR - Dollar returns

The Biomea Fusion Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Biomea Fusion Inc investment value today

Current value as on today

₹56,980

Returns

-₹43,020

(-43.02%)

Returns from Biomea Fusion Inc Stock

-₹48,996 (-49%)

Dollar Impact

₹5,976 (+5.98%)

Analyst Recommendation on Biomea Fusion Inc Stock

Based on 14 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Biomea Fusion Inc. Average target price of $6.83

Biomea Fusion Inc Share Price Target

Get share price movements and forecasts by analysts on Biomea Fusion Inc.

What analysts predicted

81.41%UPSIDE

Target Price

$6.83

Current Price

$1.27

Analyzed by

14 Analysts

Target

$6.83

Biomea Fusion Inc target price $6.83, a slight upside of 81.41% compared to current price of $1.27. According to 14 analysts rating.

Indian Investors' Interest in Biomea Fusion Inc Stock

Search interest for Biomea Fusion Inc Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:12% versus previous 30 day period

Biomea Fusion Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
6
-
-
-
1
-
-
-
-
-
Gross Profit
5
0
0
0
1
-
0
0
0
0
Operating Income
-37
-41
-38
-34
-30
-29
-21
-20
-11
-12
EBITDA
-36
-40
-38
-33
-29
-29
-20
-18
-11
-12
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-34
-39
-37
-32
-29
-29
-20
-16
4
-12
Income Tax Expense
1
0
-
0
-
-
-
-
-
-
Net Income
-34
-39
-37
-32
-29
-29
-20
-16
4
-12
Net Profit Margin
-567.96%
0.00%
0.00%
0.00%
-2401.80%
0.00%
0.00%
0.00%
0.00%
0.00%

Biomea Fusion Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
0
0
-1
-4
-1
-1
Operating Income
-1
-5
-41
-83
-126
-144
-81
EBITDA
-1
-5
-41
-82
-124
-142
-79
Interest Expense
-
-
0
1
-
-
-
Depreciation
-
0
0
0
1
1
1
Income Before Tax
-1
-5
-41
-81
-117
-138
-61
Income Tax Expense
0
0
0
-1
-
-
-
Net Income
-1
-5
-41
-80
-117
-138
-61
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Biomea Fusion Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-39
-37
-32
-29
-29
-20
-16
4
-12
Operating Cash Flow
-32
-32
-25
-30
-25
-19
-12
-13
-11
Investing Cash Flow
0
0
0
0
-
-
-
-
0
Financing Cash Flow
0
1
0
0
3
39
2
22
-
Change in Cash
-31
-31
-25
-29
-22
20
-9
9
-10

Biomea Fusion Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-41
-81
-117
-138
-61
Operating Cash Flow
-4
-35
-62
-96
-119
-70
Investing Cash Flow
0
-33
27
-2
0
-
Financing Cash Flow
65
153
1
163
1
67
Change in Cash
61
84
-33
64
-118
-2

Global Institutional Holdings in Biomea Fusion Inc

Funds
Holdings
Blue Owl Capital Holdings LP
2.18%
Susquehanna International Group, LLP
0.87%
Fideuram - Intesa Sanpaolo Private Banking Spa
0.77%
Adage Capital Partners Gp LLC
0.84%
AQR Capital Management LLC
0.57%

Insights on Biomea Fusion Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 28.8% return, outperforming this stock by 77.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Biomea Fusion, Inc. Common Stock has experienced a drawdown of -97.0%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 81.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, BMEA stock has moved down by -97.0%

About Biomea Fusion Inc

Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It's lead clinical program's drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of icovamenib for treating insulin-deficient type 2 diabetes; and COVALENT-212, which is in Phase II clinical trial of icovamenib for the treatment of type 2 diabetes. The company is also developing BMF-650, which is in Phase I glucagon-like peptide-131 clinical trial for the treatment of obesity. The company was incorporated in 2017 and is headquartered in San Carlos, California.
OrganisationBiomea Fusion Inc
Headquarters1599 Industrial Road, San Carlos, CA, United States, 94070
IndustryBiotechnology
CEODr. Michael J. M. Hitchcock Ph.D.
E-voting on sharesClick here to vote

Key Management of Biomea Fusion Inc

Name

Title

Mr. Ravi Upasani Ph.D.

Executive Vice President of Intellectual Property

Dr. Michael J. M. Hitchcock Ph.D.

Interim CEO & Director

Mr. Ramses M. Erdtmann

Co-Founder, President, COO & Director

Mr. Heow Tan

Chief Technical & Quality Officer

Caroline Perez- Dupont J.D.

Senior Vice President of Legal

Dr. Thorsten Kirschberg Ph.D.

Executive Vice President of Research

Dr. Stephan Morris M.D.

Chief Development Officer

FAQs

What is Biomea Fusion Inc share price today?

Biomea Fusion Inc share price today is $1.27 as on at the close of the market. Biomea Fusion Inc share today touched a day high of $1.37 and a low of $1.27.

What is the 52 week high and 52 week low for Biomea Fusion Inc share?

Biomea Fusion Inc share touched a 52 week high of $3.08 on and a 52 week low of $0.87 on . Biomea Fusion Inc stock price today i.e. is closed at $1.27,which is 58.77% down from its 52 week high and 45.66% up from its 52 week low.

What is Biomea Fusion Inc's market capitalisation today?

Biomea Fusion Inc market capitalisation is $0.00T as on .

How to invest in Biomea Fusion Inc Stock (BMEA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biomea Fusion Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biomea Fusion Inc Shares that will get you 1.1811 shares as per Biomea Fusion Inc share price of $1.27 per share as on June 8, 2026 at 8:46 am IST.

What is the minimum amount required to buy Biomea Fusion Inc Stock (BMEA) from India?

Indian investors can start investing in Biomea Fusion Inc (BMEA) shares with as little as ₹95.7075 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.07 in Biomea Fusion Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Biomea Fusion Inc share’s latest price of $1.27 as on June 8, 2026 at 8:46 am IST, you will get 7.8740 shares of Biomea Fusion Inc. Learn more about fractional shares .

What are the returns that Biomea Fusion Inc has given to Indian investors in the last 5 years?

Biomea Fusion Inc stock has given -93.8% share price returns and 30.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?